InMed Pharmaceuticals Inc at Emerging Growth Conference Transcript
Welcome back, everyone. Next up, we have InMed Pharmaceuticals Inc., trades on the Nasdaq under the symbol INM and as a biopharmaceutical company that specializes in developing novel therapies for diseases with high unmet medical need through the research and development of the extensive pharmacology of rare cannabinoids, coupled with diverse manufacturing technologies to provide rare cannabinoids to the health and wellness sector.
Please welcome its CEO, Eric Adams. Welcome, Eric, happy to have you on our conference today.
Thank you for having me today. Appreciate it.
All right. Whenever you're ready, Eric. The floor is yours.
Great. Thank you. So I just want to walk everyone through a brief introduction to the company and some of the technologies that we're
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |